10.1002/gps.2811 129 ParryS
Adapted from: Colunga Biancatelli RML, Berrill M, Catravas JD, Marik PE
Patients should be counseled that current evidence supporting peptides is largely preclinical, that human surgical outcomes are poorly studied, and that product purity and sterility cannot be assumed
Rotate injection sites slightly across your cycle to prevent tissue irritation from repeated injections in the same location
Knowing how B12 injections work and keeping an eye on how well theyre working is vital
Side effect comparison: Nausea: Tirzepatide rates range from 12% to 33% depending on dose, comparable to cagrilintide Vomiting: Tirzepatide higher than cagrilintide Diarrhea: Similar rates Injection site reactions: Cagrilintide significantly higher than tirzepatide Fatigue: Tirzepatide fatigue is commonly reported, comparable to cagrilintide Some researchers are exploring cagrilintide combined with tirzepatide for potentially enhanced effects